200 related articles for article (PubMed ID: 33990545)
21. Antibody-mediated inhibition of syndecan-4 dimerisation reduces interleukin (IL)-1 receptor trafficking and signalling.
Godmann L; Bollmann M; Korb-Pap A; König U; Sherwood J; Beckmann D; Mühlenberg K; Echtermeyer F; Whiteford J; De Rossi G; Pap T; Bertrand J
Ann Rheum Dis; 2020 Apr; 79(4):481-489. PubMed ID: 32094158
[TBL] [Abstract][Full Text] [Related]
22. Decrease of MLK4 prevents hepatocellular carcinoma (HCC) through reducing metastasis and inducing apoptosis regulated by ROS/MAPKs signaling.
Li Y; Zuo H; Wang H; Hu A
Biomed Pharmacother; 2019 Aug; 116():108749. PubMed ID: 31071576
[TBL] [Abstract][Full Text] [Related]
23. The tumor suppressor function of LECT2 in human hepatocellular carcinoma makes it a potential therapeutic target.
Ong HT; Tan PK; Wang SM; Hian Low DT; Ooi LL; Hui KM
Cancer Gene Ther; 2011 Jun; 18(6):399-406. PubMed ID: 21394108
[TBL] [Abstract][Full Text] [Related]
24. Blocking autophagy enhances the apoptosis effect of bufalin on human hepatocellular carcinoma cells through endoplasmic reticulum stress and JNK activation.
Hu F; Han J; Zhai B; Ming X; Zhuang L; Liu Y; Pan S; Liu T
Apoptosis; 2014 Jan; 19(1):210-23. PubMed ID: 24114361
[TBL] [Abstract][Full Text] [Related]
25. IL-17 predicts the effect of TACE combined with apatinib in hepatocellular carcinoma.
Wu Y; Cheng G; Chen H; Wang J; Wang J; Wang W
Clin Hemorheol Microcirc; 2021; 77(1):37-47. PubMed ID: 32651310
[TBL] [Abstract][Full Text] [Related]
26. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
27. Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPARγ.
Han M; Gao H; Ju P; Gao MQ; Yuan YP; Chen XH; Liu KL; Han YT; Han ZW
Biomed Pharmacother; 2018 Jul; 103():272-283. PubMed ID: 29656183
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of terminal differentiation induced ncRNA (TINCR) suppresses proliferation and invasion in hepatocellular carcinoma by targeting the miR-218-5p/DEAD-box helicase 5 (DDX5) axis.
Zhao H; Xie Z; Tang G; Wei S; Chen G
J Cell Physiol; 2020 Oct; 235(10):6990-7002. PubMed ID: 31994189
[TBL] [Abstract][Full Text] [Related]
29. Novel urokinase-plasminogen activator inhibitor SPINK13 inhibits growth and metastasis of hepatocellular carcinoma in vivo.
Wei L; Lun Y; Zhou X; He S; Gao L; Liu Y; He Z; Li B; Wang C
Pharmacol Res; 2019 May; 143():73-85. PubMed ID: 30862605
[TBL] [Abstract][Full Text] [Related]
30. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
[TBL] [Abstract][Full Text] [Related]
31. Bufalin and cinobufagin induce apoptosis of human hepatocellular carcinoma cells via Fas- and mitochondria-mediated pathways.
Qi F; Inagaki Y; Gao B; Cui X; Xu H; Kokudo N; Li A; Tang W
Cancer Sci; 2011 May; 102(5):951-8. PubMed ID: 21288283
[TBL] [Abstract][Full Text] [Related]
32. Anti-tumor activity and apoptosis-regulation mechanisms of bufalin in various cancers: new hope for cancer patients.
Yin PH; Liu X; Qiu YY; Cai JF; Qin JM; Zhu HR; Li Q
Asian Pac J Cancer Prev; 2012; 13(11):5339-43. PubMed ID: 23317181
[TBL] [Abstract][Full Text] [Related]
33. Expression and roles of syndecan-4 in dental epithelial cell differentiation.
Yan Z; Chen G; Yang Y; Sun L; Jiang Z; Feng L; Yu M; Guo W; Tian W
Int J Mol Med; 2014 Nov; 34(5):1301-8. PubMed ID: 25174688
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1.
Yang PW; Lu ZY; Pan Q; Chen TT; Feng XJ; Wang SM; Pan YC; Zhu MH; Zhang SH
Phytomedicine; 2019 Apr; 57():18-29. PubMed ID: 30668319
[TBL] [Abstract][Full Text] [Related]
35. Syndecan-4 Modulates Epithelial Gut Barrier Function and Epithelial Regeneration in Experimental Colitis.
Fröhling M; Tepasse P; Intemann J; Sambale M; Sherwood J; Paruzel P; Tiemeyer NM; Nowacki TM; Brückner M; Mennigen R; Lügering A; Echtermeyer F; Pap T; Stratis A; Bettenworth D
Inflamm Bowel Dis; 2018 Nov; 24(12):2579-2589. PubMed ID: 30053064
[TBL] [Abstract][Full Text] [Related]
36. The CCCTC-binding factor (CTCF)-forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinoma.
Zhang B; Zhang Y; Zou X; Chan AW; Zhang R; Lee TK; Liu H; Lau EY; Ho NP; Lai PB; Cheung YS; To KF; Wong HK; Choy KW; Keng VW; Chow LM; Chan KK; Cheng AS; Ko BC
J Pathol; 2017 Dec; 243(4):418-430. PubMed ID: 28862757
[TBL] [Abstract][Full Text] [Related]
37. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinoma.
Liu Y; Sun L; Su X; Guo S
Biomed Pharmacother; 2016 Dec; 84():237-243. PubMed ID: 27662474
[TBL] [Abstract][Full Text] [Related]
39. Novel strategies for hepatocellular carcinoma based on MMPs science.
Okazaki I; Inagaki Y
Anticancer Agents Med Chem; 2012 Sep; 12(7):753-63. PubMed ID: 22292750
[TBL] [Abstract][Full Text] [Related]
40. MiR-132 inhibits cell proliferation, invasion and migration of hepatocellular carcinoma by targeting PIK3R3.
Liu K; Li X; Cao Y; Ge Y; Wang J; Shi B
Int J Oncol; 2015 Oct; 47(4):1585-93. PubMed ID: 26252738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
